204 related articles for article (PubMed ID: 31018022)
1. Differential tissue expression of extracellular vesicle-derived proteins in prostate cancer.
Duijvesz D; Rodriguez-Blanco G; Hoogland AM; Verhoef EI; Dekker LJ; Roobol MJ; van Leenders GJLH; Luider TM; Jenster G
Prostate; 2019 Jun; 79(9):1032-1042. PubMed ID: 31018022
[TBL] [Abstract][Full Text] [Related]
2. Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
Duijvesz D; Burnum-Johnson KE; Gritsenko MA; Hoogland AM; Vredenbregt-van den Berg MS; Willemsen R; Luider T; Paša-Tolić L; Jenster G
PLoS One; 2013; 8(12):e82589. PubMed ID: 24391718
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Fujita K; Kume H; Matsuzaki K; Kawashima A; Ujike T; Nagahara A; Uemura M; Miyagawa Y; Tomonaga T; Nonomura N
Sci Rep; 2017 Feb; 7():42961. PubMed ID: 28211531
[TBL] [Abstract][Full Text] [Related]
4. FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer.
Cao Z; Xu Y; Guo F; Chen X; Ji J; Xu H; He J; Yu Y; Sun Y; Lu X; Wang F
Dis Markers; 2020; 2020():3904947. PubMed ID: 32655718
[TBL] [Abstract][Full Text] [Related]
5. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
[TBL] [Abstract][Full Text] [Related]
6. The Proteome of Primary Prostate Cancer.
Iglesias-Gato D; Wikström P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hägglöf C; Cox J; Andrén O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
Eur Urol; 2016 May; 69(5):942-52. PubMed ID: 26651926
[TBL] [Abstract][Full Text] [Related]
7. PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis.
Carleton NM; Zhu G; Gorbounov M; Miller MC; Pienta KJ; Resar LMS; Veltri RW
Prostate; 2018 May; 78(7):547-559. PubMed ID: 29520928
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicle Proteome in Prostate Cancer: A Comparative Analysis of Mass Spectrometry Studies.
Bernardino RMM; Leão R; Henrique R; Pinheiro LC; Kumar P; Suravajhala P; Beck HC; Carvalho AS; Matthiesen R
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948404
[TBL] [Abstract][Full Text] [Related]
9. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
Ciardiello C; Leone A; Lanuti P; Roca MS; Moccia T; Minciacchi VR; Minopoli M; Gigantino V; De Cecio R; Rippa M; Petti L; Capone F; Vitagliano C; Milone MR; Pucci B; Lombardi R; Iannelli F; Di Gennaro E; Bruzzese F; Marchisio M; Carriero MV; Di Vizio D; Budillon A
J Exp Clin Cancer Res; 2019 Jul; 38(1):317. PubMed ID: 31319863
[TBL] [Abstract][Full Text] [Related]
10. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.
Cao W; Li F; Yao J; Yu J
BMC Cancer; 2015 Nov; 15():915. PubMed ID: 26582057
[TBL] [Abstract][Full Text] [Related]
11. Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer.
Zhang H; Qi C; Wang A; Yao B; Li L; Wang Y; Xu Y
J Exp Clin Cancer Res; 2013 Oct; 32(1):77. PubMed ID: 24422979
[TBL] [Abstract][Full Text] [Related]
12. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
[TBL] [Abstract][Full Text] [Related]
13. Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death.
Mortezavi A; Salemi S; Rupp NJ; Rüschoff JH; Hermanns T; Poyet C; Randazzo M; Simon HU; Moch H; Sulser T; Wild P; Eberli D
Oncotarget; 2017 May; 8(19):31765-31774. PubMed ID: 28423666
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
15. Palmitoylation is a post-translational modification of Alix regulating the membrane organization of exosome-like small extracellular vesicles.
Romancino DP; Buffa V; Caruso S; Ferrara I; Raccosta S; Notaro A; Campos Y; Noto R; Martorana V; Cupane A; Giallongo A; d'Azzo A; Manno M; Bongiovanni A
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2879-2887. PubMed ID: 30251702
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer.
Signore M; Alfonsi R; Federici G; Nanni S; Addario A; Bertuccini L; Aiello A; Di Pace AL; Sperduti I; Muto G; Giacobbe A; Collura D; Brunetto L; Simone G; Costantini M; Crinò L; Rossi S; Tabolacci C; Diociaiuti M; Merlino T; Gallucci M; Sentinelli S; Papalia R; De Maria R; Bonci D
Cell Death Dis; 2021 Jun; 12(7):636. PubMed ID: 34155195
[TBL] [Abstract][Full Text] [Related]
17. Expression of tSTAT3, pSTAT3
Krzyzanowska A; Don-Doncow N; Marginean FE; Gaber A; Watson RW; Hellsten R; Bjartell A
Prostate; 2019 May; 79(7):784-797. PubMed ID: 30905090
[TBL] [Abstract][Full Text] [Related]
18. Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile.
Vermassen T; D'Herde K; Jacobus D; Van Praet C; Poelaert F; Lumen N; Callewaert N; Decaestecker K; Villeirs G; Hoebeke P; Van Belle S; Rottey S; Delanghe J
J Clin Pathol; 2017 Oct; 70(10):838-846. PubMed ID: 28360190
[TBL] [Abstract][Full Text] [Related]
19. High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma.
Ghods R; Ghahremani MH; Madjd Z; Asgari M; Abolhasani M; Tavasoli S; Mahmoudi AR; Darzi M; Pasalar P; Jeddi-Tehrani M; Zarnani AH
Cancer Immunol Immunother; 2014 Dec; 63(12):1319-27. PubMed ID: 25186610
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
